Iguana is a modern hybrid cannabis strain derived from a genetic crossing of Blueberry and Nepal-Indica. Its history and specific breeding origin remain undocumented, with no centralized record confirming the individual or organization responsible for its initial development. As a modern hybrid, it does not hold status as a landrace or heirloom variety, but rather functions as a contemporary cross that draws upon its diverse parentage to define its growth characteristics and chemical composition.

The sensory profile of Iguana is defined by an extensive terpene hierarchy, led by myrcene as the primary constituent. This dominant profile is followed by limonene, caryophyllene, pinene, and ocimene, with beta-pinene, nerolidol, bisabolol, and humulene serving as the tertiary components. In cultivation, the plant maintains a moderate difficulty level and reaches maturity with a 65-day flowering cycle. It is highly versatile, thriving in both indoor and outdoor environments while offering a high yield potential to the cultivator.

Iguana is a THC-dominant strain that primarily serves to promote feelings of relaxation, happiness, and an uplifted mood. Its therapeutic profile makes it an appropriate choice for users seeking support for stress and pain management, as well as assistance with sleep. To date, there are no recorded instances of notable offspring stemming from this specific genetic line.